Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,299 papers from all fields of science
Search
Sign In
Create Free Account
stage II non-small cell lung cancer
Known as:
Stage II Non-Small Cell Carcinoma of the Lung
, stage II nonsmall cell lung cancer
, lung cancer, non-oat cell, stage II
Expand
Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Chest
EGFR Gene Mutation
EGFR gene
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Poster ViewingSBRT for Stage II NSCLC: An Analysis of the National Cancer Database
S. Yan
,
M. M. Qureshi
,
M. Truong
,
K. Mak
2017
Corpus ID: 80216273
2014
2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in…
F. Kocher
,
A. Pircher
,
+8 authors
R. Greil
Lung Cancer
2014
Corpus ID: 206752159
2012
2012
Lung cancer in Berlin - Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008
T. Blum
,
S. Eggeling
,
+11 authors
A. Jagota
2012
Corpus ID: 70674347
Backgroud: The Tumorzentrum Berlin (TZB) amalgamates the clinical data of lung cancer pts. in order to improve pt. care by means…
Expand
2011
2011
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer (NSCLC).
R. Salloum
,
T. Smith
,
J. Elston-Lafata
,
G. Jensen
Journal of Clinical Oncology
2011
Corpus ID: 33419436
7067 Background: Evidence-based guidelines recommend chemotherapy for medically fit NSCLC stage II-IV patients. Understanding the…
Expand
Review
2010
Review
2010
Adjuvant therapy in early-stage non-small cell lung cancer.
M. Serke
Frontiers of radiation therapy and oncology
2010
Corpus ID: 23633876
Evidence clearly supports adjuvant chemotherapy following resection in patients with stage II or III non-small cell lung cancer…
Expand
2007
2007
Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study.
K. Syrigos
,
M. Konstantinou
,
+6 authors
C. Roussos
Anticancer Research
2007
Corpus ID: 38691298
BACKGROUND The aim of this study was to determine the overall survival, progression-free survival, and toxicity associated with…
Expand
2007
2007
The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
T. Szöke
,
K. Kayser
,
+5 authors
H. Gabius
European Journal of Cardio-Thoracic Surgery
2007
Corpus ID: 14929710
2004
2004
Vinorelbine (NVB)-based triplet with ifosfamide (IFO) and cisplatin (NIP) as induction chemotherapy (CT) to increase resection rate in marginally unresectable non-small cell lung cancer (NSCLC…
M. Gottfried
,
R. Ramlau
,
+5 authors
D. Grunenwald
Journal of Clinical Oncology
2004
Corpus ID: 21272727
7165 Background: Combined strategy CT+surgery is currently considered the best option treatment for pts with locally advanced (LA…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE